Welcome to chemicalbook!
WhatsApp
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Pharmaceutical intermediates>Heterocyclic compound>Pyridine compound>Benzylpyridinium>Evatanepag
Evatanepag
  • Evatanepag

Evatanepag NEW

Price $64 $163 $263
Package 1mg 5mg 10mg
Supply Ability: 10g
Update Time: 2026-08-04

Product Details

Product Name: Evatanepag CAS No.: 223488-57-1
Purity: 99.68% Supply Ability: 10g
Release date: 2026/08/04

Product Introduction

Bioactivity

NameEvatanepag
DescriptionEvatanepag (CP-533536 free acid) is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.CP-533536 demonstrated the ability to heal fractures when administered locally as a single dose in rat models of fracture healing.
In vitroCP-533536 is a potent and selective EP2agonist. CP-533536 shows the ability to heal fractures when administered locally as a single dose in rat models of fracture healing s excellent in vitro potency and it also displays against EP2 and selectivity against a broad panel of other targets.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 32.00 mg/mL (68.29 mM), Sonication is recommended.
KeywordsProstaglandinReceptor | Prostaglandin Receptor | PGE2 | mast cell | Inhibitor | inhibit | inflammation | HDM | Fracture healing | Evatanepag | CP-533536 | CP533536 | CP 533536 | bone | asthma | allergy
Inhibitors RelatedAngoroside C | Ufenamate | Pranoprofen | Tranilast | Rutin | Ozagrel | Ethamsylate | Rebamipide | Evodiamine | Lornoxicam | Nepafenac | p-Hydroxycinnamic acid
Related Compound LibrariesBioactive Compounds Library Max | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | ReFRAME Related Library | Bioactive Compound Library | Antioxidant Compound Library | Drug Repurposing Compound Library | Immunology/Inflammation Compound Library | Clinical Compound Library | GPCR Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$1.10
VIP6Y
Shaanxi Dideu Medichem Co. Ltd
2025-06-25
$9.80
VIP7Y
Career Henan Chemical Co
2020-01-14

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY